IDEXX Shareholders Equity Per Share from 2010 to 2024

IDXX Stock  USD 491.29  6.50  1.31%   
IDEXX Laboratories Shareholders Equity Per Share yearly trend continues to be fairly stable with very little volatility. Shareholders Equity Per Share is likely to outpace its year average in 2024. During the period from 2010 to 2024, IDEXX Laboratories Shareholders Equity Per Share regression line of annual values had r-squared of  0.42 and arithmetic mean of  5.04. View All Fundamentals
 
Shareholders Equity Per Share  
First Reported
2010-12-31
Previous Quarter
17.87169239
Current Value
18.77
Quarterly Volatility
6.28001084
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.7 M, Interest Expense of 37.7 M or Total Revenue of 3.8 B, as well as many exotic indicators such as Price To Sales Ratio of 13.22, Dividend Yield of 0.0013 or PTB Ratio of 32.61. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
  
This module can also supplement IDEXX Laboratories' financial leverage analysis and stock options assessment as well as various IDEXX Laboratories Technical models . Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Latest IDEXX Laboratories' Shareholders Equity Per Share Growth Pattern

Below is the plot of the Shareholders Equity Per Share of IDEXX Laboratories over the last few years. It is IDEXX Laboratories' Shareholders Equity Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
Shareholders Equity Per Share10 Years Trend
Slightly volatile
   Shareholders Equity Per Share   
       Timeline  

IDEXX Shareholders Equity Per Share Regression Statistics

Arithmetic Mean5.04
Geometric Mean2.57
Coefficient Of Variation124.57
Mean Deviation4.66
Median4.75
Standard Deviation6.28
Sample Variance39.44
Range19.9775
R-Value0.64
Mean Square Error24.82
R-Squared0.42
Significance0.01
Slope0.91
Total Sum of Squares552.14

IDEXX Shareholders Equity Per Share History

2024 18.77
2023 17.87
2022 7.28
2021 8.1
2020 7.41
2019 2.06
2018 -0.11

About IDEXX Laboratories Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include IDEXX Laboratories income statement, its balance sheet, and the statement of cash flows. IDEXX Laboratories investors use historical funamental indicators, such as IDEXX Laboratories's Shareholders Equity Per Share, to determine how well the company is positioned to perform in the future. Although IDEXX Laboratories investors may use each financial statement separately, they are all related. The changes in IDEXX Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IDEXX Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on IDEXX Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Shareholders Equity Per Share 17.87  18.77 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:
Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.121
Earnings Share
10.06
Revenue Per Share
44.073
Quarterly Revenue Growth
0.088
Return On Assets
0.2283
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.